Short Term Prognosis in Patients with Diabetes Mellitus after Coronary Revascularization

ABSTRACT

Background:Cardiovascular disease often advances rapidly in people with diabetes mellitus, resulting in unfavorable clinical outcomes and complications after revascularization procedures. The purpose of our study was to determine how baseline parameters and Diabetes Mellitus (DM) affected clinical outcomes in the immediate aftermath of revascularization. Materials and Methods:For this investigation, 189 patients who underwent CABG (Coronary Artery Bypass Graft) and PCI (Percutaneous Coronary Intervention) operations for revascularization during a five-month period in a South Indian tertiary care hospital were the subject of a hospital-based prospective observational analysis. During the first 30 days following revascularization, patients were assessed for clinical outcomes and baseline characteristics in the diabetic and non-diabetic groups. To ascertain the relevance of the findings, statistical analyses were carried out. Results:The study reveals that there is no statistically significant difference in the type of surgery, number of grafts or stents, urgency of the surgery, angiographic finding, length of ventilation, volume of the chest drain, stay in the cardiothoracic unit, and length of hospitalization between the diabetes and non-diabetic cohorts. Arrhythmia, stroke after revascularization, re-exploration within discharge mortality, pulmonary embolism, hemorrhage, perioperative mortality, and postoperative mortality within 30 days were evaluated as follow-up events in both the groups and determined to be insignificant. Conclusion:Even though prevalence of Cardiovascular Disease (CVD) is higher in diabetics, when comparing the diabetic and non-diabetic cohorts, it is not regarded as a risk factor for any negative outcomes following revascularization immediately within a period of thirty days following the angioplasty.

KEYWORDS

• Coronary artery bypass graft
• Coronary Revascularization
• Diabetes mellitus
• Clinical outcome
• Coronary artery disease
• Percutaneous coronary intervention

Showing references and in-text citations exactly as published.

• DOI10.5530/jyp.2024.16.11Copy

RELATED ARTICLES

Matched on section and article type within this issue of JYP.

• Article · VOLUME 16, ISSUE 1Cardioprotective Potential of Cardiboost, a Standardized Extract from Terminalia arjuna Bark against H2O2 Induced Oxidative Stress in H9c2 CardiomyocytesKuluvar Gouthamchandra, Heggar Venkataramana Sudeep, Amritharaj Amritharaj, Anusha Sathish, Lingaraju Harakanahalli Basavegowda, T. P Prasanna Kumar, Shyam Prasad Kodimule · pp. 10–16Original ArtcileSame type: Article
• Article · VOLUME 16, ISSUE 1Innovative Formulation of Tridax procumbens Ethosomes: A Study on Properties and Drug Release KineticsVinitha Vinayagam, Kamatchi Palaniraja, Yuvanishi Ravi, Aravindhan Jayashankar, Vijayan Venugopal · pp. 17–23Original ArtcileSame type: Article
• Article · VOLUME 16, ISSUE 1Synthetic and in vivo Antiepileptic Activity of “Benzene Sulfonic Acid and its Derivatives”Rohit Jaysing Bhor, Sanket Satish Patare, Rahul Bapusaheb Shirole, Karan Suresh Kadam, Mahesh Hari Kolhe, Rajshree Ghogare · pp. 24–32Original ArtcileSame type: Article
• Article · VOLUME 16, ISSUE 1Delta-9-tetrahydrocannabinol Ameliorates D-galactose/ Aluminium Chloride-Induced Alzheimer’s-Like Cognitive Deficit in Rats via Neurogenesis in their HippocampusFatin Nadzirah Zakaria, Mohamad Aris Mohd Moklas, Mohamad Taufik Hidayat Baharuldin, Che Norma Mat Taib, Hasiah Ab Hamid, Hafizah Abdul Hamid, Samaila Musa Chiroma · pp. 33–41Original ArtcileSame type: Article